Concepedia

Kyoko Okazaki

KO

Statistics

Publications

6

Citations

338

H-Index

6

Active since

1997

Affiliations

Shimane University(Current)

Ajinomoto (Japan)

Kyoko Okazaki is an author at Shimane University specializing in pharmacology, life sciences, and cell biology.

Publications per year

1997–2020

6

Publications

6

Advanced Glycation End Products (AGEs), but not High Glucose, Inhibit the Osteoblastic Differentiation of Mouse Stromal ST2 Cells Through the Suppression of Osterix Expression, and Inhibit Cell Growth and Increasing Cell Apoptosis

Kyoko Okazaki, Toru Yamaguchi, Ken-ichiro Tanaka et al. · Calcified Tissue International · 2012 · 97 citations

Life Sciences, Biochemistry, Cell Biology +12

Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (−)‐N‐(trans‐4‐isopropylcyclohexane‐carbonyl)‐<scp>d</scp>‐phenylalanine (A‐4166)

Takao Ikenoue, Megumi Akiyoshi, Shoji Fujitani et al. · British Journal of Pharmacology · 1997 · 92 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Advanced Glycation End Product 3 (AGE3) Suppresses the Mineralization of Mouse Stromal ST2 Cells and Human Mesenchymal Stem Cells by Increasing TGF-β Expression and Secretion

Masakazu Notsu, Toru Yamaguchi, Kyoko Okazaki et al. · Endocrinology · 2014 · 64 citations · Full text

Medicine, Endocrinology, Aging +15

Cystitis-Related Bladder Pain Involves ATP-Dependent HMGB1 Release from Macrophages and Its Downstream H2S/Cav3.2 Signaling in Mice

Shiori Hiramoto, Maho Tsubota, Kaoru Yamaguchi et al. · Cells · 2020 · 48 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

The ability of a new hypoglycaemic agent, A‐4166, compared to sulphonylureas, to increase cytosolic Ca<sup>2+</sup> in pancreatic β‐cells under metabolic inhibition

Shoji Fujitani, Kyoko Okazaki, Toshihiko Yada · British Journal of Pharmacology · 1997 · 26 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

1–5 of 6